Medical device companies selling into multiple countries don’t answer to one global regulator. They navigate a patchwork of national requirements that two organizations are trying to align in very different ways. 

When President Donald Trump announced a wave of tariffs in early 2025, he launched a war of words. Threats and counterthreats flew across the Atlantic and Pacific in a swirl of escalation, retaliation, and reprieve.

The ongoing AI boom seems to permeate, and sometimes call into doubt, every aspect of almost everybody’s profession.

A CEO doesn’t need to read every AI law to understand why regulation matters. It shows up in subtler ways: a sales team using a chatbot with client data, a hiring manager testing an AI screening tool, a board member asking whether the company has an AI policy.

Some of my colleagues have recently been pushing multivariate charts. These charts combine several different process outcome values into a single number that’s placed on a chart.

There’s a number that stopped me in my tracks recently. U.S.

Ask a leadership team how many hours went into last quarter’s operating review. Then ask how many of those hours went into a problem the team had already solved once before. Watch how the room reacts to the second question.

Product compliance is moving beyond certificates and restricted-substance checks.

“Just when I thought I was out, they pull me back in.”
—Michael Corleone, The Godfather: Part III

In the electrotechnology sector, we know one thing for certain: Trust can’t be imposed; it must be built. Standardization enables us to build it every day.